These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
69 related articles for article (PubMed ID: 9155148)
1. [Acquisition of resistance to anticancer agents by overproduction of target enzymes]. Inaba M Nihon Rinsho; 1997 May; 55(5):1030-7. PubMed ID: 9155148 [TBL] [Abstract][Full Text] [Related]
2. Biological activity of the multitargeted antifolate, MTA (LY231514), in human cell lines with different resistance mechanisms to antifolate drugs. Schultz RM; Chen VJ; Bewley JR; Roberts EF; Shih C; Dempsey JA Semin Oncol; 1999 Apr; 26(2 Suppl 6):68-73. PubMed ID: 10598558 [TBL] [Abstract][Full Text] [Related]
3. Thymidylate synthase as a target for growth inhibition in methotrexate-sensitive and -resistant human head and neck cancer and leukemia cell lines. McGuire JJ; Magee KJ; Russell CA; Canestrari JM Oncol Res; 1997; 9(3):139-47. PubMed ID: 9220499 [TBL] [Abstract][Full Text] [Related]
4. Genetic determinants of methotrexate responsiveness and resistance in colon cancer cells. Morales C; Ribas M; Aiza G; Peinado MA Oncogene; 2005 Oct; 24(45):6842-7. PubMed ID: 16007155 [TBL] [Abstract][Full Text] [Related]
5. Gene amplification and drug resistance in mammalian cells. Schimke RT; Brown PC; Kaufman RJ Natl Cancer Inst Monogr; 1982; 60():79-86. PubMed ID: 7121575 [TBL] [Abstract][Full Text] [Related]
6. Gene expression profiling of leukemia T-cells resistant to methotrexate and 7-hydroxymethotrexate reveals alterations that preserve intracellular levels of folate and nucleotide biosynthesis. Fotoohi AK; Assaraf YG; Moshfegh A; Hashemi J; Jansen G; Peters GJ; Larsson C; Albertioni F Biochem Pharmacol; 2009 Apr; 77(8):1410-7. PubMed ID: 19426680 [TBL] [Abstract][Full Text] [Related]
7. [Mice transduced with double-mutant dihydrofolate reductase-cytidine deaminase fusion gene attained protection from high dose chemotherapy]. Lu P; Lu Y; Pang K; Wang SB; Chen JQ; Xu HM; Wang JK; Zhao SC Zhonghua Wai Ke Za Zhi; 2005 Aug; 43(15):998-1001. PubMed ID: 16194358 [TBL] [Abstract][Full Text] [Related]
8. Mechanisms of acquired chemoresistance to 5-fluorouracil and tomudex: thymidylate synthase dependent and independent networks. Wang W; McLeod HL; Cassidy J; Collie-Duguid ES Cancer Chemother Pharmacol; 2007 May; 59(6):839-45. PubMed ID: 17119966 [TBL] [Abstract][Full Text] [Related]
9. Gene amplification and altered enzymes as mechanisms for the development of drug resistance. Bertino JR; Carman MD; Weiner HL; Cashmore A; Moroson BA; Srimatkandada S; Schornagel JH; Medina WD; Dube SK Cancer Treat Rep; 1983 Oct; 67(10):901-4. PubMed ID: 6354438 [TBL] [Abstract][Full Text] [Related]
10. Mechanisms of methotrexate resistance in osteosarcoma. Guo W; Healey JH; Meyers PA; Ladanyi M; Huvos AG; Bertino JR; Gorlick R Clin Cancer Res; 1999 Mar; 5(3):621-7. PubMed ID: 10100715 [TBL] [Abstract][Full Text] [Related]
12. Dihydropyrimidine dehydrogenase but not thymidylate synthase expression is associated with resistance to 5-fluorouracil in colorectal cancer. Nita ME; Tominaga O; Nagawa H; Tsuruo T; Muto T Hepatogastroenterology; 1998; 45(24):2117-22. PubMed ID: 9951876 [TBL] [Abstract][Full Text] [Related]
13. Dihydrofolate reductase binding and cellular uptake of nonpolyglutamatable antifolates: correlates of cytotoxicity toward methotrexate-sensitive and -resistant human head and neck squamous carcinoma cells. Chen G; Wright JE; Rosowsky A Mol Pharmacol; 1995 Oct; 48(4):758-65. PubMed ID: 7476904 [TBL] [Abstract][Full Text] [Related]
14. Molecular mechanisms of resistance to antifolates, a review. Banerjee D; Ercikan-Abali E; Waltham M; Schnieders B; Hochhauser D; Li WW; Fan J; Gorlick R; Goker E; Bertino JR Acta Biochim Pol; 1995; 42(4):457-64. PubMed ID: 8852336 [TBL] [Abstract][Full Text] [Related]
15. Methotrexate resistance conferred by transplantation of drug-resistant transgenic marrow cells fractionated bycounterflow elutriation. James R; May C; Diers M; Wagner J; McIvor R Bone Marrow Transplant; 1999 Oct; 24(8):815-21. PubMed ID: 10516690 [TBL] [Abstract][Full Text] [Related]
16. Drug efflux transporter multidrug resistance-associated protein 5 affects sensitivity of pancreatic cancer cell lines to the nucleoside anticancer drug 5-fluorouracil. Nambaru PK; Hübner T; Köck K; Mews S; Grube M; Payen L; Guitton J; Sendler M; Jedlitschky G; Rimmbach C; Rosskopf D; Kowalczyk DW; Kroemer HK; Weiss FU; Mayerle J; Lerch MM; Ritter CA Drug Metab Dispos; 2011 Jan; 39(1):132-9. PubMed ID: 20930123 [TBL] [Abstract][Full Text] [Related]
17. [Establishment of a multidrug-resistant cell line BEL-7402/5-FU of human hepatocellular carcinoma and its biological characteristics]. Gu W; Zhang YN; Li B; Han J; Cheng BB; Ling CQ Zhong Xi Yi Jie He Xue Bao; 2006 May; 4(3):265-70. PubMed ID: 16696913 [TBL] [Abstract][Full Text] [Related]
18. Cell cycle regulation of the G0/G1 transition in 5-fluorouracil-sensitive and -resistant human colon cancer cell lines. McGinn CJ; Pestalozzi BC; Drake JC; Glennon MC; Kunugi K; Otterson G; Allegra CJ; Johnston PG; Kinsella TJ Cancer J; 2000; 6(4):234-42. PubMed ID: 11038143 [TBL] [Abstract][Full Text] [Related]
19. Involvement of Nrf2 activation in resistance to 5-fluorouracil in human colon cancer HT-29 cells. Akhdar H; Loyer P; Rauch C; Corlu A; Guillouzo A; Morel F Eur J Cancer; 2009 Aug; 45(12):2219-27. PubMed ID: 19524433 [TBL] [Abstract][Full Text] [Related]
20. [The correlation between thymidylate synthase expression and cytotoxicity of 5-fluorouracil in human cancer cell lines: study using polyclonal antibody against recombinant human thymidylate synthase]. Okabe H; Tsujimoto H; Fukushima M Gan To Kagaku Ryoho; 1997 Apr; 24(6):705-12. PubMed ID: 9126308 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]